Moneycontrol
HomeNewsBusinessCoronavirus bringing record $1 trillion of new global corporate debt in 2020: Report
Trending Topics

Coronavirus bringing record $1 trillion of new global corporate debt in 2020: Report

The unprecedented increase will see total global corporate debt jump by 12 percent to around $9.3 trillion.

July 13, 2020 / 08:24 IST
Story continues below Advertisement

Companies around the world will take on as much as $1 trillion of new debt in 2020, as they try to shore up their finances against the coronavirus, a new study of 900 top firms has estimated.

The unprecedented increase will see total global corporate debt jump by 12 percent to around $9.3 trillion, adding to years of accumulation that has left the world's most indebted firms owing as much as many medium-sized countries.

Story continues below Advertisement

Last year also saw a sharp 8 percent rise, driven by mergers and acquisitions, and by firms borrowing to fund share buybacks and dividends. But this year's jump will be for an entirely different reason - preservation as the virus saps profits.

"COVID has changed everything," said Seth Meyer, a portfolio manager at Janus Henderson, the firm that compiled the analysis for a new corporate debt index. "Now it is about conserving capital and building a fortified balance sheet".

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show